Sign in
4

Changes in Ownership

Climb Bio, Inc. Filed Acc 0001104659-21-106405

Director bought 3,200,000 shares at $12.50 ($40,000,000)

  • Director acquired 6,867,517 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

RA CAPITAL MANAGEMENT, L.P. · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-08-12 Conversion : show line 1 in the form +4,727,585 7,594,804 I
2021-08-12 Purchase : show line 2 in the form +3,004,782 $12.50 $37,559,775 10,599,586 I
2021-08-12 Conversion : show line 3 in the form +1,226,497 1,226,497 I
2021-08-12 Conversion : show line 4 in the form +288,461 288,461 I
2021-08-12 Purchase : show line 5 in the form +195,218 $12.50 $2,440,225 483,679 I
2021-08-12 Conversion : show line 6 in the form +624,974 841,087 I
Open-market purchases · 3,200,000 sh · avg $12.50 · $40,000,000

Table II: Derivative

8 lines
Date Transaction Shares Owned after D/I
2021-08-12 Conversion : show line 7 in the form Series A Preferred Stock −2,639,507 0 I
2021-08-12 Conversion : show line 8 in the form Series A-1 Preferred Stock −1,415,002 0 I
2021-08-12 Conversion : show line 9 in the form Series B Preferred Stock −673,076 0 I
2021-08-12 Conversion : show line 10 in the form Series A Preferred Stock −708,333 0 I
2021-08-12 Conversion : show line 11 in the form Series A-1 Preferred Stock −518,164 0 I
2021-08-12 Conversion : show line 12 in the form Series B Preferred Stock −288,461 0 I
2021-08-12 Conversion : show line 13 in the form Series A Preferred Stock −485,493 0 I
2021-08-12 Conversion : show line 14 in the form Series A-1 Preferred Stock −139,481 0 I
Loading xslF345X03/tm2125234-1_4.xml…